GUFIC BIOSCIENCES
Back to Balance Sheet
|
GUFIC BIOSCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹160 Cr | ₹181 Cr | ₹188 Cr |
What is the latest Total Non-Current Liabilities ratio of GUFIC BIOSCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹160 Cr |
| Mar2025 | ₹181 Cr |
| Mar2024 | ₹188 Cr |
How is Total Non-Current Liabilities of GUFIC BIOSCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹160 Cr | -11.73 | |
| Mar2025 | ₹181 Cr | -3.83 | |
| Mar2024 | ₹188 Cr | - | |
Compare Total Non-Current Liabilities of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹4,255.2 Cr | -5.2% | -0.4% | 21.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -5.2% |
-0.4% |
21.2% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses